Basal Regimens
Basal Regimens is a therapeutic strategy in insulin therapy that refers to a sustained, low-level insulin delivery protocol designed to maintain glucose homeostasis during fasting states and between meals, distinguishing it from bolus-based approaches aimed at managing postprandial glucose excursions.
598
Publications
27.2K
Citations
2.7K
Authors
927
Institutions
Publications per year
2017–2026
90
Variants
Basal Insulin Regimens
Parents
598
Basal Insulin Therapy in Type 2 Diabetes
Julio Rosenstock, Sherwyn Schwartz, Charles M. Clark et al. · Diabetes Care · 2001 · 481 citations · Full text
Simon Heller, John B. Buse, Miles Fisher et al. · The Lancet · 2012 · 401 citations
1–5 of 598
2.7K
12
h-index
8
h-index
7
h-index
6
h-index
6
h-index
1–5 of 2.7K
927

Novo Nordisk (Denmark)
Copenhagen, Denmark
31 h-index
79 publications
8.2K citations
Eli Lilly (United States)
Indianapolis, United States
13 h-index
50 publications
3.9K citations

University of Georgia
Athens, United States
12 h-index
30 publications
965 citations
Dallas Diabetes Research Center
Dallas, United States
11 h-index
11 publications
1.8K citations
Emory University
Atlanta, United States
9 h-index
50 publications
8.4K citations
The Ohio State University
Columbus, United States
9 h-index
18 publications
689 citations
University of Illinois Urbana-Champaign
Urbana, United States
9 h-index
27 publications
1.2K citations
Sanofi (United States)
Bridgewater, United States
8 h-index
10 publications
636 citations
1–8 of 927
40 publications · 6K citations
34
h-index
70 publications · 3K citations
34
h-index
39 publications · 1.3K citations
22
h-index
Repository · 30 publications · 1.4K citations
20
h-index
17 publications · 1.2K citations
14
h-index
1–5